Carbahal Olsen Financial Services Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$376K Hold
2,975
0.26% 26
2026
Q1
$415K Sell
2,975
-5
-0.2% -$700 0.33% 23
2025
Q4
$366K Sell
2,980
-7
-0.2% -$851 0.28% 23
2025
Q3
$334K Buy
2,987
+12
+0.4% +$1.36K 0.27% 26
2025
Q2
$330K Sell
2,975
-460
-13% -$49K 0.28% 25
2025
Q1
$385K Hold
3,435
0.37% 18
2024
Q4
$317K Buy
+3,435
New +$309K 0.29% 23

Other funds holding GILD

Carbahal Olsen Financial Services Group's GILD Position: Q2 2026 in Review

Carbahal Olsen Financial Services Group held its Gilead Sciences (GILD) position steady in Q2 2026 at 2,975 shares worth $376K. The position accounts for 0.26% of the portfolio, ranked #26.

Carbahal Olsen Financial Services Group first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $415K in Q1 2026. 2,260 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Carbahal Olsen Financial Services Group held 2,975 shares of Gilead Sciences worth $376K as of Q2 2026.
  • Carbahal Olsen Financial Services Group left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.26% of Carbahal Olsen Financial Services Group's portfolio in Q2 2026, its #26 holding.
  • Carbahal Olsen Financial Services Group first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Carbahal Olsen Financial Services Group's Gilead Sciences position peaked at $415K in Q1 2026.
  • 2,260 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Carbahal Olsen Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.